DE60229126D1 - Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs - Google Patents

Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs

Info

Publication number
DE60229126D1
DE60229126D1 DE60229126T DE60229126T DE60229126D1 DE 60229126 D1 DE60229126 D1 DE 60229126D1 DE 60229126 T DE60229126 T DE 60229126T DE 60229126 T DE60229126 T DE 60229126T DE 60229126 D1 DE60229126 D1 DE 60229126D1
Authority
DE
Germany
Prior art keywords
hbv
vaccine
virus
hepatitis
adjuvans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60229126T
Other languages
English (en)
Inventor
Hong-Mo Moon
Ki-Yong Kim
Jung-Sun Yum
Byung-Cheol Ahn
Su-Young Yi
Young Seomun
Ji-Hee Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dobeel Corp
Original Assignee
Dobeel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dobeel Corp filed Critical Dobeel Corp
Application granted granted Critical
Publication of DE60229126D1 publication Critical patent/DE60229126D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60229126T 2001-05-25 2002-05-02 Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs Expired - Lifetime DE60229126D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20010029002 2001-05-25
PCT/KR2002/000820 WO2002094866A1 (en) 2001-05-25 2002-05-02 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine

Publications (1)

Publication Number Publication Date
DE60229126D1 true DE60229126D1 (de) 2008-11-13

Family

ID=19709949

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60229126T Expired - Lifetime DE60229126D1 (de) 2001-05-25 2002-05-02 Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs

Country Status (7)

Country Link
US (1) US20040137016A1 (de)
EP (1) EP1390397B1 (de)
KR (1) KR100587944B1 (de)
AT (1) ATE409705T1 (de)
DE (1) DE60229126D1 (de)
ES (1) ES2315405T3 (de)
WO (1) WO2002094866A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103380A2 (en) * 2007-02-21 2008-08-28 Fox Chase Cancer Center Hepatitis b virus compositions and methods of use
CA2756206A1 (en) 2009-03-27 2010-09-30 Academia Sinica Methods and compositions for immunization against virus
WO2012146630A1 (en) 2011-04-29 2012-11-01 F. Hoffmann-La Roche Ag N-terminal acylated polypeptides, methods for their production and uses thereof
KR20230156963A (ko) * 2014-10-07 2023-11-15 엠와이알 게엠베하 Hbv 및 hdv 감염의 조합 치료법
CN114729010A (zh) * 2019-08-29 2022-07-08 维尔生物科技有限公司 乙型肝炎病毒疫苗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847080A (en) * 1984-03-07 1989-07-11 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
JPS62236496A (ja) * 1986-04-07 1987-10-16 Green Cross Corp:The ＨＢｓＡｇの製造方法

Also Published As

Publication number Publication date
ATE409705T1 (de) 2008-10-15
EP1390397B1 (de) 2008-10-01
EP1390397A1 (de) 2004-02-25
KR20040018379A (ko) 2004-03-03
US20040137016A1 (en) 2004-07-15
KR100587944B1 (ko) 2006-06-08
WO2002094866A1 (en) 2002-11-28
ES2315405T3 (es) 2009-04-01

Similar Documents

Publication Publication Date Title
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
NO940660L (no) HLA - begrensete Hepatit B virus CTL-epitoper
AU6616301A (en) Modification of hepatitis b core antigen
DK1296711T3 (da) HPV-E7 til behandling af humant papillomavirus
DE60119968D1 (en) Hepatitis c tripeptid inhibitoren
NO20050396L (no) Adjuvant viral partikkel
ATE512976T1 (de) Hemmer des hepatitis-c-virus
DE60334205D1 (en) Heterocyclische sulfonamid-hepatitis-c-virus-hemmer
DE60324552D1 (en) Substituierte cycloalkyl p1' hepatitis c virus inhibitoren
EP1200109A4 (de) Verwendung von peptid-nukleinsäureverbindungen zur auslösung zellulärer immunantworten gegen hepatitis c
EA200701869A1 (ru) Пептидомиметические ингибиторы протеазы
HK1037639A1 (en) Particles of hcv envelope proteins: use for vaccination hcv.
ATE402715T1 (de) Hcv-impfstoff zusammensetzungen
HK1081207A1 (en) Hbv precore protein capable of forming particles
ATE170220T1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
MX2009000650A (es) Vacunas para malaria.
EA200300129A1 (ru) Очистка антигенов вируса гепатита b (hbv) для применения в вакцинах
WO2003004627A3 (fr) Lignees d'hepatomes humains leurs optentions et leurs applications
DE60229126D1 (de) Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
TR200202169T1 (tr) Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri.
RU2004104357A (ru) Вакцинный состав, потенцированный комбинацией днк и антигена
DE69814884D1 (de) Hepatitis b virale polypeptide
ATE476197T1 (de) Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon
AU2001270226A1 (en) Tolerance and chronic hepatitis c virus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition